Search: id:"swepub:oai:DiVA.org:oru-37561" >
The neutrophil seri...
-
Peng, XiangLinköpings universitet,Avdelningen för läkemedelsforskning,Hälsouniversitetet,Jinan University, Guangdong, China
(author)
The neutrophil serine protease PR3 induces shape change of platelets via the Rho/Rho kinase and Ca2+ signaling pathways
- Article/chapterEnglish2014
Publisher, publication year, extent ...
-
Oxon, United Kingdom :Elsevier,2014
-
printrdacarrier
Numbers
-
LIBRIS-ID:oai:DiVA.org:oru-37561
-
https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-37561URI
-
https://doi.org/10.1016/j.thromres.2014.06.001DOI
-
https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-111292URI
Supplementary language notes
-
Language:English
-
Summary in:English
Part of subdatabase
Classification
-
Subject category:ref swepub-contenttype
-
Subject category:art swepub-publicationtype
Notes
-
Funding Agencies:Swedish Renal FoundationAsp Foundation
-
Funding Agencies|Swedish Renal Foundation; Asp Foundation
-
Introduction: Proteinase 3 (PR3) is released from neutrophil azurophilic granules and exerts complex effects on the inflammatory process. PR3 catalyzes the degradation of a number of macromolecules, but the consequences on blood cells are less well defined. In the present study, the effect of PR3 on human platelets was thoroughly investigated.Methods: The experiments were performed on washed platelets freshly isolated from blood donated by healthy human volunteers. Platelets shape change and aggregation was measured on a Chrono-Log aggregometer. The phosphorylated form of MYPT1 was visualized by immunostaining. Platelet activation was further evaluated by flow cytometry.Results: PR3 induced platelet shape change but not aggregation. Flow cytometry analysis showed that PR3 induced no P-selectin expression or binding of fibrinogen to the platelets, and it did not change the activation in response to PAR1- or PAR4-activating peptides or to thrombin. Furthermore, Fura-2 measurement and immuno-blotting analysis, respectively, revealed that PR3 stimulated small intracellular Ca2+ mobilization and Thr696-specific phosphorylation of the myosin phosphatase target subunit 1 (MYPT1). Separate treatment of platelets with the Rho/Rho kinase inhibitor Y-27632 and the intracellular Ca2+ chelator BAPTA/AM reduced the shape change induced by PR3 whereas concurrent treatment completely inhibited it.Conclusion: The data shows that the neutrophil protease PR3 is a direct modulator of human platelets and causes shape change through activation of the Rho/Rho kinase and Ca2+ signaling pathways. This finding highlights an additional mechanism in the complex interplay between neutrophils and platelets.
Subject headings and genre
Added entries (persons, corporate bodies, meetings, titles ...)
-
Ramström, Sofia,1973-Linköpings universitet,Avdelningen för mikrobiologi och molekylär medicin,Hälsouniversitetet(Swepub:liu)sofra86
(author)
-
Kurz, TinoLinköpings universitet,Avdelningen för läkemedelsforskning,Hälsouniversitetet(Swepub:liu)tinku34
(author)
-
Grenegård, Magnus,1963-Linköpings universitet,Örebro universitet,Institutionen för läkarutbildning,Department of Medical and Health Sciences, Linköping University, Linköping, Sweden;,Avdelningen för läkemedelsforskning,Hälsouniversitetet,University of Örebro, Sweden(Swepub:liu)maggr06
(author)
-
Segelmark, MårtenÖstergötlands Läns Landsting,Linköpings universitet,Avdelningen för läkemedelsforskning,Hälsouniversitetet,Njurmedicinska kliniken US(Swepub:liu)marse71
(author)
-
Linköpings universitetAvdelningen för läkemedelsforskning
(creator_code:org_t)
Related titles
-
In:Thrombosis ResearchOxon, United Kingdom : Elsevier134:2, s. 418-4250049-38481879-2472
Internet link
Find in a library
To the university's database